Is VBIO or QYLD a better dividend investment in 2026?

VBIO currently yields 512.82% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: VBIO offers higher current income.

What is the dividend yield difference between VBIO and QYLD?

VBIO has a forward dividend yield of 512.82% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 500.90 percentage points.

Home › Compare › VBIO vs QYLD

VBIO vs QYLD: Dividend Comparison 2026

VBIO yields 512.82% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VBIO wins by $74719.35M in total portfolio value

INVESTMENT

TIME HORIZON10 years

VBIO

● Live price

512.82%

Share price

$0.39

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$74719.37M

Annual income

$54,003,807,702.14

Full VBIO calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — VBIO vs QYLD

📍 VBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VBIO	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VBIO + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VBIO pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VBIO

Annual income on $10K today (after 15% tax)

$43,589.74/yr

After 10yr DRIP, annual income (after tax)

$45,903,236,546.82/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, VBIO beats the other by $45,903,231,736.41/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VBIO + QYLD for your $10,000?

VBIO: 50%QYLD: 50%

100% QYLD50/50100% VBIO

Portfolio after 10yr

$37359.70M

Annual income

$27,001,906,680.73/yr

Blended yield

72.28%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VBIO buys

QYLD buys

No recent congressional trades found for VBIO or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVBIOQYLD

Forward yield	512.82% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$74719.37M ✓	$25.4K
Annual income after 10y	$54,003,807,702.14 ✓	$5,659.31
Total dividends collected	$72929.43M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: VBIO vs QYLD ($10,000, DRIP)

Year	VBIO Portfolio	VBIO Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$61,982	$51,282.05	$10,352	$1,192.36	+$51.6K → VBIO
2	$363,383	$297,062.31	$10,830	$1,347.57	+$352.6K → VBIO
3	$2,016,476	$1,627,655.79	$11,460	$1,539.07	+$2.01M → VBIO
4	$10,598,885	$8,441,255.59	$12,275	$1,777.84	+$10.59M → VBIO
5	$52,806,644	$41,465,837.52	$13,323	$2,078.95	+$52.79M → VBIO
6	$249,582,121	$193,079,012.24	$14,667	$2,463.34	+$249.57M → VBIO
7	$1,119,909,823	$852,856,952.70	$16,396	$2,960.57	+$1119.89M → VBIO
8	$4,774,834,551	$3,576,531,040.71	$18,631	$3,612.97	+$4774.82M → VBIO
9	$19,360,340,566	$14,251,267,596.86	$21,548	$4,482.15	+$19360.32M → VBIO
10	$74,719,372,108	$54,003,807,702.14	$25,398	$5,659.31	+$74719.35M → VBIO

VBIO vs QYLD: Complete Analysis 2026

VBIO — Stock

Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.

Full VBIO Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this VBIO vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VBIO vs SCHD VBIO vs JEPI VBIO vs O VBIO vs KO VBIO vs MAIN VBIO vs XYLD VBIO vs JEPQ VBIO vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.